Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIqgeo Regulatory News (IQG)

Share Price Information for Iqgeo (IQG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 467.00
Bid: 462.00
Ask: 472.00
Change: 0.00 (0.00%)
Spread: 10.00 (2.165%)
Open: 467.00
High: 467.00
Low: 467.00
Prev. Close: 467.00
IQG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

12 Nov 2015 07:00

RNS Number : 4315F
Ubisense Group PLC
12 November 2015
 

12.11.15

 

Ubisense Group PLC (the "Company")

 

Trading Update

 

Ubisense ("Ubisense" or the "Company") (LON:UBI), a market leader in enterprise location intelligence solutions, announces an update on current trading and an outlook for the current financial year ending 31 December 2015 ("FY15").

 

The Geospatial division has continued to trade satisfactorily. There is some significant deal concentration weighted towards the final weeks of FY15, in addition there is a good pipeline of opportunities to close for both FY15 and 2016. During the period the Company deployed with a number of its strategic partners, demonstrating ongoing demand for its solutions as well as validating its partner channel approach.

 

The RTLS division has been materially impacted by the recent well-publicised challenges facing the Company's large automotive customers, in Germany especially, and this has resulted in the downscaling, delay or cancellation of certain major deployment contracts and a likely lengthening of customer decision cycles in the wider industry.

 

Due to these unforeseen circumstances, there is a risk of a material revenue and subsequent profit shortfall against previous guidance for FY15. The Board's estimate is that second half revenues will now be in the range of £12.6-14.6 million (as against first half revenues of £10.4 million) and that full year FY15 revenues will therefore be in the range of £23-25 million. This range of outcomes should result in at least a small positive adjusted EBITDA for the second half, before non-recurring costs, but an adjusted EBITDA loss for the full year FY15.

 

As previously announced and as part of the stated strategic restructuring, the Board implemented some significant cost reduction initiatives early in the second half, resulting in annualised savings of £2.0 million. Given the challenging trading conditions highlighted above, the Board has decided to implement further cost actions over the coming months, with a view to achieving further annualised savings of approximately £3 million. A further exceptional charge of £1.7 million is expected in the second half of FY15 in relation to these measures, bringing the total exceptional charge in FY15 to £3.6 million.

 

Cash conversion this year has been adversely affected by restructuring costs and extended payment terms on certain contracts, impacting the collection of receivables. Gross cash at the end of October 2015 was £4.8 million, with £5.3 million drawn under the Company's available debt facilities, giving a net debt position of £0.5 million. The Company expects to remain in a gross cash, but net debt position, as at 31 December 2015. Management is in regular dialogue with its principal lender, HSBC, who remain supportive and in constructive discussion to support the Company's on-going requirements. The Board is determined to ensure that the Company's cash outflow situation is rectified though improved cash conversion in 2016, coupled with the benefits of the recent and current cost alignment initiatives.

 

Peter Harverson, Chairman designate, commented:

 

"The second half of the period has been challenging for the business, driven by macro events outside of our control. Whilst disappointing to announce a reduced revenue number, the recent signing of a new automotive OEM in Spain through Atlas Copco and other strategic wins support the Board's view that the strategy in place means the Group is well positioned moving forward.

 

In the short-term, we have made some necessary decisions to right size the cost base of the business and are focused on refining our sales strategy, in particular our partner channel development, to drive revenue growth through expanded scale and reach."

 

Contact

Ubisense Group plc Tel: + 44 (0) 1223 535170

Richard Green

Tim Gingell

 

Numis Securities Limited  Tel: + 44 (0) 207 2601000

Simon Willis, Jamie Lillywhite (Corporate Finance)

Rupert Krefting (Corporate Broking)

 

Redleaf Communications   Tel: +44 (0) 20 7382 4730

Rebecca Sanders-Hewett, Richard Gotla,

David Ison, Harriet Lynch

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPKDDBKBDBADD
Date   Source Headline
24th Jan 202212:45 pmRNSDirector/PDMR Shareholding
17th Jan 20225:15 pmRNSDirector/PDMR Shareholding
14th Jan 20223:15 pmRNSHolding(s) in Company
14th Jan 202212:30 pmRNSDirector/PDMR Shareholding
12th Jan 20227:00 amRNSTrading Update
10th Jan 20227:00 amRNSLarge US telecom operator expands IQGeo footprint
5th Jan 20221:15 pmRNSHolding(s) in Company
4th Jan 20222:45 pmRNSDirector/PDMR Shareholding - Replacement
4th Jan 20221:31 pmRNSDirector/PDMR Shareholding
4th Jan 20227:00 amRNSIQGeo Signs Major US Telecom Operator
30th Dec 20211:45 pmRNSHolding(s) in Company
30th Dec 202112:00 pmRNSDirector/PDMR Shareholding
22nd Dec 20217:00 amRNSDeferred Consideration and Total Voting Rights
20th Dec 20213:45 pmRNSDirector/PDMR Shareholding
17th Dec 20213:45 pmRNSDirector/PDMR Shareholding
16th Dec 202110:30 amRNSIQGeo Selected by Major US Electrical Utility Firm
13th Dec 20214:30 pmRNSHolding(s) in Company
13th Dec 20214:15 pmRNSDirector/PDMR Shareholding
13th Dec 20217:00 amRNSExercise of Options and Total Voting Rights
6th Dec 20217:00 amRNSDirector/PDMR Shareholding
29th Nov 20213:30 pmRNSDirector/PDMR Shareholding
15th Nov 202112:15 pmRNSDirector/PDMR Shareholding
8th Nov 202112:31 pmRNSDirector/PDMR Shareholding
11th Oct 20219:15 amRNSDirector/PDMR Shareholding
27th Sep 202111:45 amRNSDirector/PDMR Shareholding
20th Sep 202112:00 pmRNSDirector/PDMR Shareholding
13th Sep 20211:30 pmRNSHolding(s) in Company
13th Sep 20217:00 amRNSHalf-year Report
9th Sep 20218:03 amRNSNew Contract Win
9th Aug 20211:15 pmRNSDirector/PDMR Shareholding
2nd Aug 20217:00 amRNSDirector/PDMR Shareholding - Grant Of Options
29th Jul 20214:00 pmRNSHolding(s) in Company
28th Jul 20211:15 pmRNSDirector/PDMR Shareholding
26th Jul 20213:45 pmRNSDirector/PDMR Shareholding
22nd Jul 202111:45 amRNSDirector/PDMR Shareholding
19th Jul 20217:00 amRNSTrading Update
14th Jul 20212:30 pmRNSDirector/PDMR Shareholding
1st Jul 20212:15 pmRNSDirector/PDMR Shareholding
30th Jun 20215:30 pmRNSDirector/PDMR Shareholding
25th Jun 202111:15 amRNSDirector/PDMR Shareholding
15th Jun 20219:00 amRNSIQGeo selected by WAPA for inspection processes
8th Jun 20219:00 amRNSDeutsche GigaNetz chooses IQGeo
3rd Jun 20219:35 amRNSDirector/PDMR Shareholding
26th May 20217:00 amRNSDirectorate Change
18th May 20213:19 pmRNSResult of Annual General Meeting
27th Apr 20218:31 amRNSDirector/PDMR Shareholding
26th Apr 20218:08 amRNSDirector/PDMR Shareholding
20th Apr 20215:22 pmRNSDirector/PDMR Shareholding
16th Apr 20219:20 amRNSPosting of the Annual Report and Notice of AGM
23rd Mar 20217:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.